How can chronic inflammation in psoriasis be managed, and when is medical treatment required in Europe?

Psoriasis and chronic inflammation explained: autoimmune skin disease, systemic inflammation, plaque psoriasis, biologic therapy, and monitoring criteria.

In this episode, we outline how psoriasis is more than a skin condition and how doctors manage inflammatory burden under EU medical guidance.

You’ll learn:

• What psoriasis is (an immune-mediated inflammatory disorder)

• Why chronic inflammation can extend beyond the skin

• Common triggers: stress, infection, skin injury, certain medications

• Topical treatments (corticosteroids, vitamin D analogues)

• When phototherapy or systemic treatments are considered

• The role of biologic therapies in moderate to severe cases

• Links between psoriasis and cardiovascular risk

• Situations where treatment escalation may require specialist referral

We explain how doctors assess plaque distribution, severity (PASI considerations), joint symptoms (psoriatic arthritis), cardiovascular risk factors, and treatment response during an online consultation in the EU. Moderate to severe psoriasis often requires coordinated dermatology follow-up.

This episode reflects the clinical standards used by Mobi Doctor, where dermatology consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/managing-chronic-inflammation-with-psoriasis